NCT00971581View on ClinicalTrials.gov

Safety, Tolerability and Efficacy Study With a Fixed-Dose Combination (FDC) Ketoprofen Plus Omeprazole

PHASE3CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

August 31, 2009

Primary Completion Date

May 31, 2010

Study Completion Date

May 31, 2010

Conditions
Pain
Interventions
DRUG

FDC KETOPROFEN+OMEPRAZOLE

Ketoprofen + Omeprazole FDC once daily for 4 weeks

Trial Locations (1)

Unknown

Sanofi-Aventis Administrative Office, Col. Coyoacan

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT00971581 - Safety, Tolerability and Efficacy Study With a Fixed-Dose Combination (FDC) Ketoprofen Plus Omeprazole | Biotech Hunter | Biotech Hunter